Phospholipase C delta 4 (PLCδ4) is a nuclear protein involved in cell proliferation and senescence in mesenchymal stromal stem cells.
Kunrath-Lima M., de Miranda MC., Ferreira ADF., Faraco CCF., de Melo MIA., Goes AM.
Laboratory Study, published in Cell Signal (2018) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Cell Signal (2018)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 29859928
- PMCID
- PMC6095203
- DOI
- 10.1016/j.cellsig.2018.05.011
- Citations
- 15
Abstract (original English)
Ca 2+ is an important second messenger, and it is involved in many cellular processes such as cell death and proliferation. The rise in intracellular Ca 2+ levels can be due to the generation of inositol 1,4,5-trisphosphate (InsP 3 ), which is a product of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) hydrolysis by phospholipases C (PLCs), that leads to Ca 2+ release from endoplasmic reticulum by InsP 3 receptors (InsP 3 R). Ca 2+ signaling patterns can vary in different regions of the cell and increases in nuclear Ca 2+ levels have specific biological effects that differ from those of Ca 2+ increase in the cytoplasm. There are PLCs in the cytoplasm and nucleus, but little is known about the functions of nuclear PLCs. This work aimed to characterize phenotypically the human PLCδ4 (hPLCδ4) in mesenchymal stem cells. This nuclear isoform of PLC is present in different cell types and has a possible role in proliferative processes. In this work, hPLCδ4 was found to be mainly nuclear in human adipose-derived mesenchymal stem cells (hASC). PLCδ4 knockdown demonstrated that it is essential for hASC proliferation, without inducing cell death. An increase of cells in G1, and a reduction of cells on interphase and G2/M in knockdown cells were seen. Furthermore, PLCδ4 knockdown increased the percentage of senescent cells, p16 INK4A+ and p21 Cip1 mRNAs expression, which could explain the
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.